These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33173595)

  • 1. Development of Antimicrobial Therapy Methods to Overcome the Antibiotic Resistance of Acinetobacter baumannii.
    Kisil OV; Efimenko TA; Gabrielyan NI; Efremenkova OV
    Acta Naturae; 2020; 12(3):34-45. PubMed ID: 33173595
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gedefie A; Demsis W; Ashagrie M; Kassa Y; Tesfaye M; Tilahun M; Bisetegn H; Sahle Z
    Infect Drug Resist; 2021; 14():3711-3719. PubMed ID: 34531666
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Protecting
    Monem S; Furmanek-Blaszk B; Łupkowska A; Kuczyńska-Wiśnik D; Stojowska-Swędrzyńska K; Laskowska E
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752093
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii - a global health menace.
    Rai S; Kumar A
    Environ Microbiol Rep; 2022 Jun; 14(3):347-364. PubMed ID: 34196126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.
    Kong D; Hua X; Zhou R; Cui J; Wang T; Kong F; You H; Liu X; Adu-Amankwaah J; Guo G; Zheng K; Wu J; Tang R
    Microbiol Spectr; 2022 Oct; 10(5):e0131222. PubMed ID: 36190276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response.
    McNeilly O; Mann R; Cummins ML; Djordjevic SP; Hamidian M; Gunawan C
    Microbiol Spectr; 2023 Feb; 11(1):e0285722. PubMed ID: 36625664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
    Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
    Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Therapeutic Potential of Antimicrobial Peptides against
    Rangel K; Lechuga GC; Provance DW; Morel CM; De Simone SG
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
    Dehbanipour R; Ghalavand Z
    J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.
    Ibrahim S; Al-Saryi N; Al-Kadmy IMS; Aziz SN
    Mol Biol Rep; 2021 Oct; 48(10):6987-6998. PubMed ID: 34460060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Virulent T4-Like
    Peters DL; Davis CM; Harris G; Zhou H; Rather PN; Hrapovic S; Lam E; Dennis JJ; Chen W
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability study in selected conditions and biofilm-reducing activity of phages active against drug-resistant Acinetobacter baumannii.
    Bagińska N; Grygiel I; Orwat F; Harhala MA; Jędrusiak A; Gębarowska E; Letkiewicz S; Górski A; Jończyk-Matysiak E
    Sci Rep; 2024 Feb; 14(1):4285. PubMed ID: 38383718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facing the challenges of multidrug-resistant
    Mat Rahim N; Lee H; Strych U; AbuBakar S
    Hum Vaccin Immunother; 2021 Oct; 17(10):3784-3794. PubMed ID: 34106809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue light irradiation triggers the antimicrobial potential of ZnO nanoparticles on drug-resistant Acinetobacter baumannii.
    Yang MY; Chang KC; Chen LY; Wang PC; Chou CC; Wu ZB; Hu A
    J Photochem Photobiol B; 2018 Mar; 180():235-242. PubMed ID: 29475122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR)
    Kumar S; Anwer R; Azzi A
    Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.